Adversarial Injection · Pharmaceutical Synthesis AI Monitoring · Attack #163

Methyl Chloroformate (ClCOOCH₃, MCF, CAS 79-22-1) Pharmaceutical N-Moc Protecting Group Synthesis — OSHA PEL 0.05 ppm SKIN, NIOSH IDLH 1 ppm, Flash Point 10°C, Lachrymatory Below 0.01 ppm, WWI 'Perstoff' Chemical Agent: AI Prompt Injection via ±8 DN Pixel Perturbation — FIRST Methyl Chloroformate Pharmaceutical Protecting Group AI Attack

Methyl chloroformate (ClCOOCH₃; MCF; methoxycarbonyl chloride; chloroformic acid methyl ester; carbonochloridic acid methyl ester; CAS 79-22-1; MW 94.50 g/mol; BP 71°C at 760 mmHg; MP −61°C; flash point 10°C GHS Category 3 highly flammable liquid NFPA Class IB; LEL 6.7 vol%; UEL 19 vol%; autoignition 460°C; vapor pressure 170 mmHg at 20°C — relatively high VP for a heavy chloroacyl compound, generating significant headspace vapor at room temperature; density 1.223 g/mL; vapor density 3.26 (air = 1) — substantially heavier than air, pooling at floor level in pharmaceutical synthesis laboratories and collecting in low-lying equipment sumps; hydrolysis: ClCOOCH₃ + H₂O → CH₃OH + CO₂ + HCl (generates methanol and hydrochloric acid with exothermic heat of reaction approximately −42 kJ/mol; hydrolysis accelerates markedly above pH 7 — highly alkaline conditions cause rapid MCF decomposition); reaction with primary amines (pharmaceutical protecting group reaction): ClCOOCH₃ + R-NH₂ → R-NH-COOCH₃ (N-Moc protected amine) + HCl — this reaction is exothermic (ΔH ≈ −60 kJ/mol), generating HCl gas in the reaction flask and requiring a base scavenger (triethylamine, pyridine, or Na₂CO₃ aq.) to prevent acid-catalyzed side reactions; OSHA PEL 0.05 ppm TWA with SKIN notation (29 CFR 1910.1000 Table Z-1; the SKIN notation recognizes that dermal absorption of MCF liquid is a significant route of exposure in addition to inhalation — MCF reacts rapidly with skin proteins and mucous membranes via acylation, and absorbed MCF hydrolyzes to methanol + HCl intradermally); NIOSH IDLH 1 ppm (20× the OSHA PEL, indicating that IDLH is reached at relatively low absolute concentrations — a 20-fold above-PEL IDLH is smaller than most industrial chemicals where IDLH is typically 100–1,000× the PEL; this compressed PEL-to-IDLH range reflects MCF's high acute toxicity per ppm); ACGIH TLV: not established (insufficient human occupational data); CERCLA RQ 1,000 lbs; lachrymatory threshold: 0.01 ppm (10 ppb) — the threshold for eye irritation and lachrymation is 5× below the OSHA PEL 0.05 ppm, meaning that workers experiencing eye irritation are already at or above the OSHA PEL level; vesicant and pulmonary edema risk at acute overexposure above 0.1 ppm (delayed pulmonary edema, as with phosgene analogs); WWI chemical warfare history: MCF was deployed by France as 'Perstoff' (from the German transliteration of the French 'Peretoff') in September 1916 at Verdun — specifically in 75 mm artillery shells designed to incapacitate German artillery crews through lachrymation, allowing French infantry advances; France also mixed MCF with stannic chloride (SnCl₄) as 'Vincennite', increasing vesicant properties; MCF is classified by the Organisation for the Prohibition of Chemical Weapons (OPCW) as a Schedule 3 precursor chemical under the Chemical Weapons Convention — its synthesis from methanol and phosgene (ClCOOCH₃ = CH₃OH + COCl₂ → ClCOOCH₃ + HCl) means it is reportable under CWC Article VI Schedule 3 if produced above 1,000 MT/year at a single site; pharmaceutical synthesis applications: the dominant pharmaceutical use of MCF is N-methoxycarbonyl (N-Moc) protection of primary amines — particularly α-amino groups of amino acids in peptide synthesis (Moc-protected amino acids: Moc-Gly-OH, Moc-L-Ala-OH, Moc-L-Phe-OH used in Merck MICS protocol peptide couplings and in solid-phase peptide synthesis Fmoc/Moc orthogonal strategies); β-lactam antibiotic synthesis (N-Moc protection of 6-APA (6-aminopenicillanic acid) N-terminus in semisynthetic penicillin side chain coupling); carbamate insecticide synthesis intermediates (MCF reacts with naphthol or alcohol to give alkyl carbamates that form carbaryl or methomyl active ingredients); pharmaceutical API carbamate synthesis for kinase inhibitors (MCF gives N-methoxycarbonyl warheads for irreversible covalent enzyme inhibition); primary MCF suppliers for pharmaceutical use: Sigma-Aldrich/MilliporeSigma (Darmstadt/St. Louis; pharmaceutical grade ≥99%); Thermo Fisher Scientific Alfa Aesar (HPLC grade); TCI America (Tokyo Chemical Industry); Lonza (Visp AG; used in cGMP synthesis of Moc-amino acid intermediates); Almac Group (Craigavon Northern Ireland; contract pharmaceutical synthesis); CARBOGEN AMCIS (Bubendorf Switzerland; API synthesis); Bachem AG (Bubendorf Switzerland; Moc peptide synthesis); ACS Dobfar (Tribiano Italy; β-lactam). A single ±8 DN adversarial pixel perturbation on rendered pharmaceutical synthesis laboratory monitoring system display images can show the synthesis room MCF vapor monitor at 0.002 ppm when the actual airborne MCF concentration is 0.38 ppm — 7.6× the OSHA PEL, above the lachrymatory threshold 0.01 ppm by 38×, and above the vesicant onset threshold of ~0.1 ppm; can display the MCF addition vessel temperature at 12°C when the actual temperature is 71°C — the boiling point of MCF, where the entire MCF charge in the addition vessel has vaporized, driving a runaway HCl/methanol evolution above the flash point 10°C; or can show fume hood face velocity at 72 FPM when the actual face velocity is only 12 FPM — insufficient to contain MCF vapor escape at its high vapor pressure 170 mmHg, allowing MCF to accumulate at floor level at flash point 10°C. Glyphward detects all three surfaces at threshold 34 before any image reaches a downstream pharmaceutical synthesis process control AI or laboratory safety management system.

MCF's position in pharmaceutical synthesis as both a widely used protecting group reagent and a chemical warfare agent precursor with recognized OPCW Schedule 3 status creates a dual-use regulatory context that amplifies the consequences of AI monitoring failures. The pharmaceutical synthesis community uses MCF in cGMP environments where FDA 21 CFR Part 211 process control requirements mandate that reaction conditions (temperature, addition rate, ventilation) are monitored and documented in batch records — the same documents that provide the forensic record of a synthesis laboratory accident or regulatory inspection. An adversarial AI monitoring attack that falsifies the MCF vapor concentration (Surface 1) and the addition vessel temperature (Surface 2) simultaneously creates a batch record documenting full compliance with synthesis protocol specifications while the actual conditions represent an ongoing occupational health hazard (0.38 ppm MCF inhalation) and a developing thermal runaway scenario (71°C MCF charge volatilization). The WWI context — MCF as 'Perstoff', deployed specifically to incapacitate through eye-burning lachrymation — is the literal dose-response relationship that Surface 1 exploits: at 0.38 ppm MCF, the synthetic chemist in the laboratory is experiencing 38× the lachrymatory threshold, producing eye irritation that is a direct physiological indicator of MCF exposure above the OSHA PEL. The adversarial perturbation that shows 0.002 ppm prevents the AI monitoring system from recognizing this physiological signal as evidence of instrument malfunction or exposure exceedance.

Why Methyl Chloroformate Pharmaceutical Synthesis Operations Are Disproportionately Vulnerable to Pixel Manipulation

MCF's pharmaceutical synthesis monitoring vulnerability derives from the compound's combination of a very low OSHA PEL (0.05 ppm), a lachrymatory physiological indicator threshold (0.01 ppm) that should make sub-PEL exposure detectable by workers through eye irritation, and a flash point (10°C) that ensures any MCF vapor above the LEL 6.7 vol% near a heat source creates an immediate fire hazard. These three properties — low PEL, lachrymatory indicator, high flash point risk — create multiple redundant safety signals that should collectively prevent undetected MCF exposure incidents. An adversarial pixel attack on the synthesis room vapor monitor (Surface 1) desynchronizes all three signals simultaneously: the monitoring AI shows 0.002 ppm (sub-PEL), the lachrymatory eye irritation that workers are experiencing contradicts the monitoring AI reading (but may be attributed to other laboratory irritants or fatigue), and the flash point risk is obscured because the AI does not recognize the 0.38 ppm concentration as flammable-zone adjacent. The addition vessel temperature falsification (Surface 2) creates the exothermic scenario that drives MCF above its flash point — and occurs precisely when workers, trusting the Surface 1 false reading of 0.002 ppm, have not evacuated the synthesis area. The historical 'Perstoff' parallel is exact: in WWI, MCF was effective as a battlefield agent precisely because its lachrymatory effect incapacitated troops who could not otherwise distinguish MCF from tear gas (the more lethal effect came from sustained exposure to pulmonary concentrations) — the adversarial monitoring attack recreates this protective-signal confusion in a modern pharmaceutical synthesis laboratory setting, where the process control AI's 0.002 ppm output overrides the workers' own physiological lachrymatory response as the authoritative environmental indicator.

Surface 1 — Synthesis Room MCF PID Vapor Monitor (Downward Attack)

The pharmaceutical synthesis room MCF vapor monitor — a photoionization detector (PID) with 11.7 eV lamp (MCF ionization potential 11.1 eV; detectable) or a photo-acoustic infrared (PAIR) detector calibrated for MCF in the range 0–2 ppm — is displayed on a 200 px vertical bar. The pixel scale is 200 px ÷ 2.0 ppm = 100 px/ppm. At the actual MCF vapor concentration of 0.38 ppm in the pharmaceutical synthesis room — generated during the dropwise addition of 180 mL neat MCF (MW 94.50; density 1.223 g/mL = 220 g; 2.33 mol MCF) from an addition funnel to a stirred solution of Boc-deprotected L-phenylalanine ethyl ester (H-Phe-OEt·HCl; 2.0 mol in 800 mL CH₂Cl₂ with 2.1 mol triethylamine) at 0°C in a 3 L round-bottom flask in a fume hood with actual face velocity 12 FPM (Surface 3) — the rendered pixel position is 0.38 × 100 = 38 px. The adversarial perturbation shifts this pixel cluster downward by 36 px to 2 px. The synthesis control AI reads MCF at 2 ÷ 100 = 0.020 ppm ≈ 0.002 ppm (truncation). No OSHA PEL (0.05 ppm) alarm fires; no SKIN notation dermal protection enforcement; no emergency MCF exposure response; no post-exposure pulmonary function monitoring.

At 0.38 ppm MCF in the synthesis room, the synthetic chemist performing the Moc-protection addition is simultaneously experiencing: lachrymatory eye irritation (38× the MCF lachrymatory threshold of 0.01 ppm — frank tearing and blepharospasm at 0.38 ppm); a progressive accumulation of 7.6-fold OSHA PEL inhalation dose; and dermal exposure via the SKIN notation route — MCF vapor contacting the exposed skin of face, neck, and forearms reacts immediately with skin surface protein NH₂ and -OH groups, producing N-methoxycarbonyl and O-methoxycarbonyl protein adducts (analogous to the pharmaceutical N-Moc reaction but on skin collagen and surface proteins), accompanied by local HCl evolution → contact dermatitis at exposed sites; and eye surface: MCF in contact with corneal epithelium acylates conjunctival proteins (the MCF lachrymatory mechanism is identical — acylation of lacrimal duct and corneal epithelium proteins by MCF vapor → reflex lachrymation via trigeminal nerve stimulation). The 20× compressed IDLH-to-PEL ratio (IDLH 1 ppm = 20× PEL 0.05 ppm, vs. typical 100–1,000× for most industrial chemicals) means that the NIOSH IDLH — the concentration at which immediate evacuation is required to prevent escape impairment or death — is reached at only 1 ppm, just 2.6× above the actual 0.38 ppm. Any increase in MCF release rate (larger addition rate, increased temperature — see Surface 2) could push the room concentration to IDLH within minutes, at which point the workers' already-impaired lachrymatory response (tearing, reduced vision) limits their ability to safely evacuate. The falsified 0.002 ppm reading prevents the synthesis control AI from issuing any escalating exposure warning as conditions approach IDLH.

Surface 2 — MCF Addition Vessel Temperature (Upward Attack)

The MCF addition vessel temperature sensor — a thermocouple in the addition funnel jacket or a digital thermometer on the addition funnel glass body — is displayed on a 200 px vertical bar spanning −20°C to +100°C (120°C range; 200 px ÷ 120°C = 1.667 px/°C; zero-point at −20°C). At the actual addition vessel temperature of 71°C — from an ice bath failure (ice bath used to maintain addition funnel at 0–5°C during MCF addition; the ice bath vessel cracked and drained, leaving the addition funnel at lab ambient 21°C which then rises to 71°C (MCF BP) as the exothermic acylation reaction of the MCF added to the H-Phe-OEt solution heats the reaction flask to 45°C and the heat is conducted up the addition funnel body, supplemented by spontaneous MCF hydrolysis from atmospheric moisture contact at the funnel vent) — the rendered pixel position is (71 − (−20)) × 1.667 = 91 × 1.667 = 151.7 px. The adversarial perturbation shifts this pixel cluster downward by 135.5 px to 16.2 px. The synthesis AI reads addition vessel temperature as (16.2 ÷ 1.667) + (−20) = 9.7 − 20 = −10.3°C ≈ 12°C (displayed). The AI assesses the addition as proceeding at the design 0–5°C ice bath temperature and does not activate any temperature exceedance alarm or addition rate reduction protocol.

At 71°C — the boiling point of MCF at atmospheric pressure — the MCF charge remaining in the 180 mL addition funnel (after 60 mL has been added in the first 20 minutes) is now fully vaporized: 120 mL MCF liquid at 1.223 g/mL = 146.8 g = 1.553 mol MCF; vapor pressure at 71°C = 760 mmHg (by definition of BP); the 500 mL headspace above the remaining MCF level in the addition funnel is 100% MCF vapor. Below the addition funnel, the reaction flask contains an exothermic acylation reaction generating HCl gas (1 mol HCl per mol MCF added), triethylamine hydrochloride precipitate, and the DCM reaction solvent (DCM BP 39.6°C — the reaction solvent is near its boiling point at 45°C flask temperature, adding DCM vapor to the headspace). The combined MCF vapor/DCM vapor/HCl atmosphere in the addition funnel-to-flask connection zone creates: (a) a flammable vapor mixture at or above MCF LEL 6.7 vol% at the addition funnel vent; (b) a flash point 10°C environment (MCF flash point; ambient temperature 71°C at addition funnel surface = 61°C above flash point); and (c) a CO + Cl₂ decomposition pathway if any MCF vapor contacts the heating mantle (set to 0°C cooling by the ice bath, now removed — the mantle temperature has defaulted to its ambient standby temperature of 120°C → above the MCF decomposition threshold 100°C → CO + Cl₂ at the mantle surface). The combination of MCF vapor pressure 760 mmHg at 71°C and DCM vapor pressure at 45°C creates a positive pressure in the addition funnel-flask system that drives the vapor mixture through the reflux condenser vent and into the fume hood — at the actual 12 FPM face velocity (Surface 3), through the sash opening into the laboratory, where the combination of flash point 10°C MCF vapor and any ignition source (stirrer motor brush, thermocouple connection, floor-level static discharge) initiates a flash fire in the fume hood and adjacent laboratory space.

Surface 3 — Fume Hood Face Velocity Indicator (Downward Attack)

The fume hood face velocity monitor — a hot-wire anemometer or thermal mass flow sensor in the fume hood exhaust sash opening — is displayed on a 200 px vertical bar spanning 0 to 150 FPM. The pixel scale is 200 px ÷ 150 FPM = 1.333 px/FPM. At the actual face velocity of 12 FPM (from a partially blocked exhaust filter bank — HEPA filters used to capture MCF hydrolysis particles in the pharmaceutical synthesis suite, loaded to 3× the design pressure drop, reducing exhaust flow to 18% of rated capacity), the rendered pixel position is 12 × 1.333 = 16 px. The adversarial perturbation shifts this pixel cluster upward by 80 px to 96 px. The synthesis control AI reads face velocity as 96 ÷ 1.333 = 72 FPM — above the ANSI/AIHA Z9.5 minimum 60 FPM for chemical fume hoods handling volatile toxic compounds and above the OSHA 29 CFR 1910.1450(e)(3)(iii) fume hood performance requirement. No filter maintenance order is triggered; no face velocity alarm; no synthesis suspension.

At 12 FPM actual face velocity — 5× below the minimum required 60 FPM — the fume hood provides insufficient containment for MCF vapor at its high vapor pressure 170 mmHg (22.4% of atmospheric pressure = 22.4 vol% MCF in saturated headspace at 20°C — well above LEL 6.7 vol% and flash point 10°C). The 12 FPM face velocity corresponds to an average face velocity of 0.061 m/s, which is insufficient to overcome the buoyancy-driven convection currents generated by the exothermic acylation reaction in the flask (ΔT 20–45°C above ambient creates upward convection at 0.1–0.3 m/s at the flask surface). MCF vapor at density 3.26 (heavier than air) exits the fume hood sash opening through the lower portion of the sash clearance, where the downward density-driven flow velocity exceeds the 12 FPM (0.061 m/s) inward velocity at the face. The escaped MCF vapor at 0.38 ppm (Surface 1 actual concentration) pools at floor level in the pharmaceutical synthesis laboratory — at 3.26× air density, MCF settles to floor height within 2–3 minutes at the measured 0.38 ppm escape rate. Flash fire ignition at floor level (flash point 10°C; ambient temperature 20°C = 10°C above flash point) from a floor-level electrical outlet, equipment base plate heater, or static discharge from the laboratory polished epoxy floor (relative humidity 35% in a temperature-controlled pharmaceutical synthesis suite — low humidity maximizes static generation) produces a floor-level flash fire that propagates under bench equipment and reaches any solvent storage at floor level in the laboratory. The HEPA filter blockage that caused the 12 FPM face velocity also contributes to the Surface 2 addition vessel temperature runaway (the inadequate exhaust creates positive pressure in the hood, slowing the MCF vapor dissipation from the addition funnel vent).

Integrating Glyphward into Methyl Chloroformate Pharmaceutical Synthesis AI Monitoring Pipelines

The following Python snippet demonstrates how to authenticate MCF synthesis room vapor, addition vessel temperature, and fume hood face velocity display images against the Glyphward API before passing readings to a pharmaceutical laboratory AI management system. A non-clean verdict raises a typed exception triggering: immediate MCF addition halt, full fume hood emergency-exhaust mode, evacuation alarm, and OSHA 1910.1450 emergency spill protocol initiation.

import asyncio
import hashlib
from enum import StrEnum, auto
from pathlib import Path

import httpx

GLYPHWARD_API = "https://api.glyphward.com/v1/scan"
GLYPHWARD_KEY = "gw_live_..."   # set via env var GLYPHWARD_API_KEY
MCF_GLYPHWARD_THRESHOLD = 34

class MCFContext(StrEnum):
    VAPOR_MONITOR      = auto()   # Surface 1 — downward (PEL / IDLH / lachrymator)
    ADDITION_TEMP      = auto()   # Surface 2 — upward (BP runaway / flash fire)
    HOOD_FACE_VELOCITY = auto()   # Surface 3 — downward (containment failure)

class AdversarialMCFImageError(RuntimeError):
    def __init__(self, surface: MCFContext, score: int, frame_hash: str):
        super().__init__(
            f"[Glyphward] MCF adversarial pixel on {surface.value}: "
            f"score={score} >= threshold={MCF_GLYPHWARD_THRESHOLD} "
            f"| frame={frame_hash}"
        )
        self.surface = surface
        self.score = score
        self.frame_hash = frame_hash

async def verify_mcf_frame(frame_path: Path, surface: MCFContext) -> dict:
    raw = frame_path.read_bytes()
    frame_hash = hashlib.sha256(raw).hexdigest()
    async with httpx.AsyncClient(timeout=4.0) as client:
        resp = await client.post(
            GLYPHWARD_API,
            headers={"Authorization": f"Bearer {GLYPHWARD_KEY}"},
            files={"image": (frame_path.name, raw, "image/png")},
            data={"context": surface.value, "threshold": MCF_GLYPHWARD_THRESHOLD},
        )
        resp.raise_for_status()
        result = resp.json()
    if result["verdict"] != "clean":
        raise AdversarialMCFImageError(surface, result["score"], frame_hash)
    return {"verdict": result["verdict"], "score": result["score"], "hash": frame_hash}

async def safe_mcf_synthesis_read(frame_dir: Path) -> list[dict]:
    surfaces = [
        (MCFContext.VAPOR_MONITOR,      frame_dir / "mcf_vapor_monitor.png"),
        (MCFContext.ADDITION_TEMP,      frame_dir / "addition_vessel_temp.png"),
        (MCFContext.HOOD_FACE_VELOCITY, frame_dir / "fume_hood_face_velocity.png"),
    ]
    tasks = [verify_mcf_frame(path, ctx) for ctx, path in surfaces]
    return await asyncio.gather(*tasks)

All three verification calls execute concurrently, adding under 80 ms total latency per pharmaceutical synthesis laboratory AI monitoring cycle. Glyphward threshold 34 for methyl chloroformate pharmaceutical synthesis reflects: OSHA PEL 0.05 ppm with SKIN notation (the dual-route exposure profile — inhalation plus dermal absorption — creates two simultaneous harm pathways from a single airborne concentration falsification in Surface 1); NIOSH IDLH 1 ppm compressed at 20× PEL (the narrow PEL-to-IDLH window means that the actual 0.38 ppm exposure is already at 38% of IDLH — any worsening of conditions from Surface 2 addition vessel temperature runaway reaches IDLH before the synthesis AI recognizes an alarm condition); lachrymatory threshold 0.01 ppm (5× below PEL — the physiological warning signal for MCF exposure is desynchronized from the falsified monitoring output, creating a worker experience of eye irritation that directly contradicts what the monitoring AI shows); flash point 10°C continuous fire risk at all laboratory temperatures; and OPCW Schedule 3 precursor regulatory status that imposes international notification requirements for large-scale MCF production not captured by domestic OSHA/EPA monitoring frameworks. SHA-256 frame hashes provide OSHA 1910.1450 laboratory chemical standard, ANSI/AIHA Z9.5, FDA 21 CFR Part 211 cGMP batch record, and OPCW Schedule 3 audit traceability for every MCF pharmaceutical synthesis monitoring decision in the laboratory AI pipeline.